Bimekizumab, CAS 1418205-77-2

Product Description: Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Shah M, et al. Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells. RMD Open. 2020 Jul;6(2):e001306.

CAS Number: 1418205-77-2

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Interleukin Related

• SKU: MEXHY-P99280-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99280-5
• Green Labware: No
• Package Unit: 5 mg
• Quantity Unit: STK